Organization
Xantho Biotechnology
2 clinical trials
Clinical trial
A Phase I/IIa Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GM-XANTHO in Healthy Volunteers and to Investigate Its Efficacy and Safety Profile in Atopic Dermatitis PatientsStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
A Phase IIa Study to Investigate the Efficacy and Safety Profile of GM-XANTHO in Pressure Ulcer PatientsStatus: Not yet recruiting, Estimated PCD: 2025-12-31